Search Results - "BESSELL, E"

Refine Results
  1. 1

    Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer by Dhadda, A.S, Dickinson, P, Zaitoun, A.M, Gandhi, N, Bessell, E.M

    Published in European journal of cancer (1990) (01-05-2011)
    “…Abstract Purpose To assess the prognostic value of the Mandard tumour regression score (TRG) following pre-operative chemo/radiotherapy in patients with…”
    Get full text
    Journal Article
  2. 2

    Long-term survival after treatment for Hodgkin’s disease (1973–2002): improved survival with successive 10-year cohorts by Bessell, E M, Bouliotis, G, Armstrong, S, Baddeley, J, Haynes, A P, O'Connor, S, Nicholls-Elliott, H, Bradley, M

    Published in British journal of cancer (24-07-2012)
    “…Background: The Nottinghamshire Lymphoma Registry contains the details of all the patients diagnosed with lymphoma (since 1 January 1973) within a defined…”
    Get full text
    Journal Article
  3. 3

    Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification by Bessell, E.M., Humber, C.E., O'Connor, S., English, J.S.E., Perkins, W., Dickinson, P.D., Patel, A.N.

    Published in British journal of dermatology (1951) (01-11-2012)
    “…Summary Background  Primary cutaneous B‐cell lymphomas (PCBCL), with the exception of large B‐cell lymphoma of leg type and intravascular large B‐cell…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Does youth adiposity, or change in adiposity from youth to adulthood, predict metabolically healthy obesity in adulthood? by Smith, K. J., Bessell, E., Magnussen, C. G., Dwyer, T., Venn, A. J.

    Published in Pediatric obesity (01-10-2016)
    “…Summary Background Individuals with metabolically healthy obesity (MHO) do not have the metabolic complications usually associated with obesity. Objective To…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life by CULLEN, M. H, BILLINGHAM, L. J, TRASK, C, BESSELL, E, CONNOLLY, C. K, TOBIAS, J, SOUHAMI, R. L, WOODROFFE, C. M, CHETIYAWARDANA, A. D, GOWER, N. H, JOSHI, R, FERRY, D. R, RUDD, R. M, SPIRO, S. G, COOK, J. E

    Published in Journal of clinical oncology (01-10-1999)
    “…Chemotherapy for non-small-cell lung cancer (NSCLC) remains controversial. We describe the two largest reported, randomized, parallel trials designed to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    MAGIC in practice: Experience of peri-operative ECF/X chemotherapy in gastro-esophageal adenocarcinomas by Reece-Smith, A.M., Saha, S., Cunnell, M.L., Hameed, K., Bessell, E.M., Duffy, J.P., Madhusudan, S., Parsons, S.L.

    Published in Journal of surgical oncology (01-11-2012)
    “…Background The MAGIC trial demonstrated the perioperative regimen of Epirubicin (E), Cisplatin (C) and 5‐Fluorouracil (F) to have an overall survival benefit…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Chemoradiotherapy with Brachytherapy or Electron Therapy Boost for Locally Advanced Squamous Cell Carcinoma of the Anus—Reducing the Colostomy Rate by Kent, C., Bessell, E. M., Scholefield, J. H., Chappell, S., Marsh, L., Mills, J., Sayers, I.

    Published in Journal of gastrointestinal cancer (01-03-2017)
    “…Purpose The aim of this study is to determine overall survival, disease-specific survival and stoma-free survival after treatment of squamous cell carcinoma of…”
    Get full text
    Journal Article
  12. 12

    CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma by Bessell, E M, Graus, F, López-Guillermo, A, Villá, S, Verger, E, Petit, J, Holland, I, Byrne, P

    “…To assess the efficacy and toxicity, including long-term neurotoxicity, of combined therapy with the CHOD/BVAM regimen given before cranial radiotherapy in the…”
    Get more information
    Journal Article
  13. 13

    Regression of Rectal Cancer with Radiotherapy with or without Concurrent Capecitabine — Optimising the Timing of Surgical Resection by Dhadda, A.S, Zaitoun, A.M, Bessell, E.M

    “…Abstract Aims To determine tumour regression (volume-halving time) obtained after chemo/radiotherapy, and thereby the ideal interval between the start of…”
    Get full text
    Journal Article
  14. 14

    Non-Hodgkin's Lymphoma of the Sinonasal Tract by Quraishi, M. S., Bessell, E. M., Clark, D., Jones, N. S., Bradley, P. J.

    Published in The Laryngoscope (01-09-2000)
    “…Objectives A review of the presenting features, management, and outcome of extranodal non‐Hodgkin's lymphoma (NHL) of the sinonasal tract during a 10‐year…”
    Get full text
    Journal Article
  15. 15
  16. 16

    An unusual case of primary anaplastic large cell central nervous system lymphoma: an 8-year success story by Vivekanandan, Sindu, Dickinson, Peter, Bessell, Eric, O'Connor, Simon

    Published in BMJ case reports (24-02-2011)
    “…Primary central nervous system anaplastic large cell lymphoma (PCNS ALCL) is rare, with only three adult patients reported. We describe a patient with PCNS…”
    Get full text
    Journal Article
  17. 17

    A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin’s lymphoma by Bessell, E. M., Burton, A., Haynes, A. P., Glaholm, J., Child, J. A., Cullen, M. H., Davies, J. M., Smith, G. M., Ellis, I. O., Jack, A., Jones, E. L.

    Published in Annals of oncology (01-02-2003)
    “…Background: The aim of this study was to determine in a randomised trial whether there is any significant difference in toxicity between modified CHOP and MCOP…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion plasmacytoma despite ongoing molecular remission by BYRNE, J. L, FAIRBAIRN, J, DAVY, B, CARTER, I. G, BESSELL, E. M, RUSSELL, N. H

    Published in Bone marrow transplantation (Basingstoke) (01-02-2003)
    “…Allogeneic SCT for myeloma may be curative for young patients, but its role remains controversial because of a reported high TRM in some series. Since 1991, we…”
    Get full text
    Journal Article
  20. 20

    Primary cutaneous marginal zone B cell lymphoma in monozygotic twins by Dickinson, P D, Patel, A, Wootton, C, Bessell, E M, O'Connor, S

    Published in BMJ case reports (03-03-2011)
    “…The authors present the first reported case of primary cutaneous marginal zone B cell lymphoma (PCMZL) in monozygotic twins. The occurrence of PCMZL in…”
    Get full text
    Journal Article